#apotex
Apotex seeks to raise C$1.2B in Toronto IPO, marking a major test for Canada’s public markets
Apotex's IPO could reshape investor confidence in Canada's market, influencing future pharmaceutical investments and market dynamics. The post Apotex seeks to raise C$1.2B in Toronto IPO, marking a major test for Canada’s public markets appeared first on Cryp…
Orbicular Wins Health Canada Nod for g-Ozempic
Orbicular secures Health Canada approval for g-Ozempic (semaglutide injection) with Apotex, expanding access to diabetes treatment options.
OneSource notches a second generic semaglutide approval in Canada, through partner
The generic version of Ozempic from Canadian-based Apotex, has been approved, Health Canada said, adding that it was the second generic approved, even as seven applications were being reviewed